Meningococcal vaccine groups B and C (GlaxoSmithKline)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeningococcal vaccine groups B and C (GlaxoSmithKline)
Drug Alias NameVA-MENGOC-BCCuban meningococcal BC vaccine
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitis, Meningococcal
Global Approved IndicationsMeningitis, Meningococcal
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCuba
Original Approved Date1989/01/01
Country/TerritoryCuba
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesFinlay Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsMeningitis, Meningococcal
Inactive IndicationsN/A

Other Information

ATC CodeJ07AH
Related LinksN/A